SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-053800
Filing Date
2010-10-14
Accepted
2010-10-14 16:23:56
Documents
8
Period of Report
2010-07-31

Document Format Files

Seq Description Document Type Size
1 v198963_10k.htm 10-K 10958987
2 GRAPHIC graph.jpg GRAPHIC 67697
3 v198963_ex10-46.htm EX-10.46 15473
4 v198963_ex21.htm EX-21 12463
5 v198963_ex23.htm EX-23 3770
6 v198963_ex31-1.htm EX-31.1 16560
7 v198963_ex31-2.htm EX-31.2 16524
8 v198963_ex32.htm EX-32 8882
  Complete submission text file 0001144204-10-053800.txt   11127512
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 101124029
SIC: 2834 Pharmaceutical Preparations